Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Furberg

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Acta Medica Scandinavica|January 1, 1977
Sudden coronary death in Scandinavia. A report from Scandinavian coronary heart disease registersC Furberg, M Romo, E Linko, et al.
Journal of Electrocardiology|April 1, 1980
The effect of modified limb electrode positions on electrocardiographic wave amplitudesP M Rautaharju, R J Prineas, R S Crow, et al.
Controlled Clinical Trials|July 31, 1998
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristicsD Grady, W Applegate, T Bush, et al.
Circulation|October 1, 1981
The randomized clinical trial: bias in analysisG S May, D L DeMets, L M Friedman, et al.
American Journal of Hypertension|January 1, 1997
ALLHAT and calcium channel blockers. ALLHAT Research GroupM Proschan, B Davis, J Cutler, et al.
Journal of the American Geriatrics Society|May 16, 2000
Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health StudyR Luoto, T Manolio, E Meilahn, et al.
JAMA|August 26, 1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupS Hulley, D Grady, T Bush, et al.
European Heart Journal|December 14, 2001
Hormone treatment--misconceptions and agreementsS B Hulley, V Bittner, C Furberg, et al.
American Journal of Epidemiology|June 15, 1994
Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health StudyL Kuller, N Borhani, C Furberg, et al.
European Heart Journal|July 1, 1985
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsS Yusuf, R Collins, R Peto, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Acta Medica Scandinavica|January 1, 1977
Sudden coronary death in Scandinavia. A report from Scandinavian coronary heart disease registersC Furberg, M Romo, E Linko, et al.
Journal of Electrocardiology|April 1, 1980
The effect of modified limb electrode positions on electrocardiographic wave amplitudesP M Rautaharju, R J Prineas, R S Crow, et al.
Controlled Clinical Trials|July 31, 1998
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristicsD Grady, W Applegate, T Bush, et al.
Circulation|October 1, 1981
The randomized clinical trial: bias in analysisG S May, D L DeMets, L M Friedman, et al.
American Journal of Hypertension|January 1, 1997
ALLHAT and calcium channel blockers. ALLHAT Research GroupM Proschan, B Davis, J Cutler, et al.
Journal of the American Geriatrics Society|May 16, 2000
Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health StudyR Luoto, T Manolio, E Meilahn, et al.
JAMA|August 26, 1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupS Hulley, D Grady, T Bush, et al.
European Heart Journal|December 14, 2001
Hormone treatment--misconceptions and agreementsS B Hulley, V Bittner, C Furberg, et al.
American Journal of Epidemiology|June 15, 1994
Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health StudyL Kuller, N Borhani, C Furberg, et al.
European Heart Journal|July 1, 1985
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsS Yusuf, R Collins, R Peto, et al.
Pageof 4